Veterinary Medicines Information website

Bovilis Bovipast RSP, injekcinė suspensija galvijams

Authorised
  • Mannheimia haemolytica, serotype A1, strain M4/1, Inactivated
  • Bovine parainfluenza virus 3, strain SF-4, Inactivated
  • Bovine respiratory syncytial virus, strain EV 908, Inactivated

Product identification

Medicine name:
Bovilis Bovipast RSP, injekcinė suspensija galvijams
Active substance:
  • Mannheimia haemolytica, serotype A1, strain M4/1, Inactivated
  • Bovine parainfluenza virus 3, strain SF-4, Inactivated
  • Bovine respiratory syncytial virus, strain EV 908, Inactivated
Target species:
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Mannheimia haemolytica, serotype A1, strain M4/1, Inactivated
    9000000000.00
    cells
    /
    1.00
    Dose
  • Bovine parainfluenza virus 3, strain SF-4, Inactivated
    199526000.00
    50% tissue culture infectious dose
    /
    1.00
    Dose
  • Bovine respiratory syncytial virus, strain EV 908, Inactivated
    2511890.00
    50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AL04
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Available in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

RV1883.pdf

Lithuanian (PDF)
Published on: 1/03/2024
Download